IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,881,000 | -24.7% | 69,157 | -68.6% | 0.00% | -33.3% |
Q2 2020 | $7,812,000 | +484.3% | 220,449 | +122.3% | 0.01% | +500.0% |
Q1 2020 | $1,337,000 | -67.3% | 99,160 | -48.7% | 0.00% | -66.7% |
Q4 2019 | $4,090,000 | +372.3% | 193,406 | +195.4% | 0.00% | +200.0% |
Q3 2019 | $866,000 | -87.9% | 65,483 | -87.3% | 0.00% | -75.0% |
Q2 2019 | $7,130,000 | -35.5% | 514,276 | -10.6% | 0.00% | -42.9% |
Q1 2019 | $11,046,000 | +47.9% | 575,120 | +9.9% | 0.01% | +40.0% |
Q4 2018 | $7,469,000 | -80.2% | 523,530 | -71.0% | 0.01% | -54.5% |
Q3 2018 | $37,643,000 | +166.1% | 1,807,267 | +202.4% | 0.01% | +175.0% |
Q2 2018 | $14,145,000 | +54.4% | 597,640 | -4.7% | 0.00% | 0.0% |
Q1 2018 | $9,162,000 | -26.4% | 627,240 | -18.5% | 0.00% | -50.0% |
Q4 2017 | $12,442,000 | -35.8% | 770,060 | -44.5% | 0.01% | -38.5% |
Q3 2017 | $19,382,000 | +417.5% | 1,386,562 | +226.8% | 0.01% | +333.3% |
Q2 2017 | $3,745,000 | +129.9% | 424,238 | +68.3% | 0.00% | +200.0% |
Q1 2017 | $1,629,000 | +624.0% | 252,116 | +309.3% | 0.00% | – |
Q4 2016 | $225,000 | +287.9% | 61,593 | +238.7% | 0.00% | – |
Q3 2016 | $58,000 | -97.4% | 18,187 | -98.1% | 0.00% | -100.0% |
Q2 2016 | $2,223,000 | +6075.0% | 959,171 | +6303.9% | 0.00% | – |
Q1 2016 | $36,000 | -84.1% | 14,978 | -79.7% | 0.00% | – |
Q4 2015 | $226,000 | +209.6% | 73,879 | +70.2% | 0.00% | – |
Q3 2015 | $73,000 | -33.6% | 43,419 | +59.4% | 0.00% | – |
Q2 2015 | $110,000 | +511.1% | 27,245 | +437.2% | 0.00% | – |
Q1 2015 | $18,000 | -78.3% | 5,072 | -71.2% | 0.00% | – |
Q4 2014 | $83,000 | +388.2% | 17,628 | +269.7% | 0.00% | – |
Q3 2014 | $17,000 | -75.0% | 4,768 | -74.4% | 0.00% | – |
Q2 2014 | $68,000 | -72.8% | 18,654 | -68.8% | 0.00% | – |
Q1 2014 | $250,000 | +76.1% | 59,851 | +92.5% | 0.00% | – |
Q4 2013 | $142,000 | -83.6% | 31,088 | -77.7% | 0.00% | -100.0% |
Q3 2013 | $864,000 | – | 139,625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |